_x000D_
Neurostimulation Devices Market Size And Forecast
_x000D_
Neurostimulation Devices Market size was valued at USD 6.06 Billion in 2021 and is projected to reach USD 17.49 Billion by 2030, growing at a CAGR of 12.50% from 2023 to 2030.
_x000D_
The growing prevalence of neurological disorders and the growing demand for minimally invasive technologies are boosting the growth of the Neurostimulation Devices Market. Additionally, a growing number of elderly patients suffering from neurological disorders is fueling the growth of the Neurostimulation Devices Market. The Global Neurostimulation Devices Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
_x000D_
>>> Get | download sample – Please Email- avni@agninews.co.in Report @ – https://www.marketresearch.com/download-sample/?rid=3588
_x000D_
_x000D_
_x000D_
_x000D_
Global Neurostimulation Devices Market Definition
_x000D_
Neurostimulation is used as an advanced treatment in some cases of chronic pain. It helps to reduce the pain and to improve the quality of life of people who are suffering from loss to sense organs and people who are paralyzed. For example, neural prosthetics for hearing aids, artificial vision, brain-machine interfaces, etc. Neurostimulation devices are surgically implanted devices in the patient’s body and they function through thin wires or leads. They can be used as a replacement for strong pain killers, including opiates. Neurostimulation devices are effective therapeutic solutions for pain that can be brought on by various medical conditions, like failed back surgery or diabetic neuropathy, etc.
_x000D_
Neurostimulation relieves pain by disrupting the pain signals that travel between the spinal cord and the brain. Neurostimulation System has several components such as Neurostimulator, leads, and patient programmer. Neurostimulator is a device that generates electrical impulses. Leads are thin, insulated medical wires that perform the function of delivering pulses to the epidural space near the spine. The patient’s programmer is a device that can be customized as per the instructions given by the doctor. Neurostimulation devices are used for the treatment of neurological disorders, such as deep brain stimulation, responsive Neurostimulation, spinal cord stimulation, motor cortex stimulation, etc. The neurostimulation system does not make any noise. It might feel like a small bump under the skin, but it is not much visible. And hence these devices can be used without any discomfort.
_x000D_
There are many advantages of using Neurostimulation devices or systems. It provides treatment focality, as they have the ability to direct therapeutic energy towards the location of concern. Hence, there are very less chances of exposure to other regions of the body. It is also a drug-free solution to reduce pain in patients. Some of the patients were getting addicted to the drugs and pain killers, so this problem is solved by the use of neurostimulation devices. This system has also provided relief to the patients where other treatments, like injections or medications, were not useful. One of the major advantages of using Neurostimulation implants is that they are not permanent.
_x000D_
>>> Ask For Discount @ – https://www.marketresearch.com/Please Email- avni@agninews.co.in/?rid=3588
_x000D_
Global Neurostimulation Devices Market Overview
_x000D_
The increasing geriatric population across the globe and the increasing prevalence of chronic diseases such as migraine and epilepsy are majorly boosting the growth of the Neurostimulation Devices Market. Neurostimulation Devices are used in the treatment of movement disorders, epilepsy, Parkinson’s disease, chronic pain, and depression for therapeutic purposes. Additionally, the introduction of advanced technology in the healthcare sector is another factor contributing to the growth of the Neurostimulation Devices Market.
_x000D_
Furthermore, the growing prevalence of neurological disorders along with lifestyle diseases and the increase in the investment by the government, as well as other private organizations to boost R&D activities in the field, is likely to propel the growth of the Neurostimulation Devices Market. As per the American Academy of Neurology, in the U.S. stroke is the third leading cause of death whereas, Alzheimer’s is in the sixth rank. Hence, a growing number of neurological disorders are fueling the growth of the Neurostimulation Devices Market. Moreover, the growing trend of minimally invasive surgeries and Neurostimulation device implantation is a minimally invasive procedure. A shorter period and fast recovery rate is accelerating the growth of the Neurostimulation Devices Market.
_x000D_
On the contrary, adverse effects associated with the implantation of Neurostimulation Devices into the body such as allergic reactions and prickling of the skin is anticipated to restrict the growth of the Neurostimulation Devices Market. Additionally, the high cost associated with the implantation of the devices and availability of alternative surgeries and drug therapies is likely to hamper the growth of the Neurostimulation Devices Market. Nevertheless, research activities regarding the management of obsessive-compulsive disorders, interstitial cystitis, and asthma are expected to provide lucrative opportunities for Neurostimulation Devices Market during the forecasted period.
_x000D_
Global Neurostimulation Devices Market Segmentation Analysis
_x000D_
The Global Neurostimulation Devices Market is Segmented on the basis of Devices Type, Application, End-User, And Geography.
_x000D_
_x000D_
Neurostimulation Devices Market, By Devices Type
_x000D_
- _x000D_
- Implantable Devices_x000D_
- _x000D_
- Vagus Nerve Stimulators
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Gastric Electric Stimulators
- Others
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
- External Devices_x000D_
- _x000D_
- Transcranial Magnetic Stimulation (TMS)
- Transcutaneous Electrical Nerve Stimulation (TENS)
- Others
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
Based on Devices Type, the market is segmented into Implantable Devices and External Devices. The spinal Cord Stimulators segment is accounted for holding the largest share in the market. Various factors driving the growth of the segment are a wide application of the segment and high market penetration. Also, technological advancement is fueling the growth of the segment.
_x000D_
Neurostimulation Devices Market, By Application
_x000D_
- _x000D_
- Parkinson’s Disease
- Epilepsy
- Depression
- Dystonia
- Pain Management
- Others
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
To Get Summarized Market Report By Application:-download sample – Please Email- avni@agninews.co.in Report Now
_x000D_
Based on Application, the market is segmented into Parkinson’s disease, Epilepsy, Depression, Dystonia, Pain Management and Others. Pain Management segment is accounted for holding largest share in the Neurostimulation Devices Market and also projected to grow with fastest CAGR during the forecasted period. Growth of the segment is attributed to huge prevalence of chronic pain and increasing need for pain management.
_x000D_
Neurostimulation Devices Market, By End-User
_x000D_
- _x000D_
- Rehabilitation Centers
- Hospitals
- Medical Clinics
- Others
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
Based on End-User, the market is segmented into Rehabilitation Centers, Hospitals, Medical Clinics, and Others. The hospital segment is expected to grow at the highest CAGR during the forecast period owing to the increasing number of patients suffering from various neurological disorders along with lifestyle diseases, and rising awareness about these disorders. Additionally, the availability of various diagnostics and treatment facilities, higher purchasing power, and the presence of highly skilled healthcare professionals are driving the growth of the Global Neurostimulation Devices market in the hospital’s segment.
_x000D_
Neurostimulation Devices Market, By Geography
_x000D_
- _x000D_
- North America
- Europe
- Asia Pacific
- Rest of the world
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
To Get Summarized Market Report By Geography:-download sample – Please Email- avni@agninews.co.in Report Now
_x000D_
On the basis of Regional Analysis, the Global Neurostimulation Devices Market is classified into North America, Europe, Asia Pacific, and Rest of the world. North America is accounted for holding the largest share of the market due to the increasing geriatric population in the region and Asia-Pacific is projected to grow with the highest CAGR during the forecasted period due to the developing healthcare infrastructure in the region.
_x000D_
Key Players
_x000D_
The “Global Neurostimulation Devices Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Boston Scientific Corporation, St. Jude Medical, Inc., Cochlear, Ltd., Medtronic, Plc, NDI Medical, LLC, MED-EL., Cyberonics, Inc. NeuroSigma, Inc., and NeuroPace, Inc.
_x000D_
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
_x000D_
Key Developments
_x000D_
_x000D_
- _x000D_
- In January 2022, Medtronic Plc announced the approval of its Intellis rechargeable neurostimulator and Vanta recharge-free neurostimulator platform for the treatment of chronic pain associated with diabetic peripheral neuropathy (DPN) by the US FDA.
- In January 2021, Boston Scientific Corporation launched WaveWriter Alpha Spinal Cord Stimulator Systems, in US which was a unified portfolio of four MRI conditional, Bluetooth-enabled rechargeable and non-rechargeable implantable pulse generators (IPGs) offers uncompromised personalization, and for the first time in Spinal Cord Stimulation (SCS), Fast Acting Sub-perception Therapy (FAST) mainly designed to provide profound paresthesia-free pain relief in a moment.
- In September 2019, Abbott’s Proclaim XR™ recharge free neurostimulation platform for people suffering from chronic pain was approved by the US FDA. This approval helped Abbott to increase its neurostimulation devices product portfolio and secure a higher market share.
- In April 2017, Boston Scientific Corporation announced the successful implantation of their first patient in the PRISM (Precision Implantable Stimulator for Migraine) clinical study.
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
Report Scope
_x000D_
REPORT ATTRIBUTES | DETAILS |
---|---|
Study Period |
2018-2030 _x000D_ |
Base Year |
2021 _x000D_ |
Forecast Period |
2023-2030 _x000D_ |
Historical Period |
2018-2020 _x000D_ |
Unit |
Value (USD Billion) _x000D_ |
Key Companies Profiled |
Boston Scientific Corporation, St. Jude Medical, Inc., Cochlear, Ltd., Medtronic, Plc, NDI Medical, LLC, MED-EL., Cyberonics, Inc., NeuroSigma, Inc., and NeuroPace, Inc. _x000D_ |
Segments Covered |
By Devices Type, By Application, By End-User, And By Geography _x000D_ |
Customization Scope |
Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. _x000D_ |
_x000D_
Top Trending Reports
_x000D_
Global Battery Manufacturing Equipment Market Size And Forecast
_x000D_
Global Adherence Packaging Market Size And Forecast
_x000D_
Global Led Driver Market Size And Forecast
_x000D_
Research Methodology of Market Research:
_x000D_
_x000D_
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Market Research.
_x000D_
Reasons to Purchase this Report
_x000D_
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
_x000D_
• Provision of market value (USD Billion) data for each segment and sub-segment
_x000D_
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
_x000D_
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
_x000D_
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
_x000D_
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
_x000D_
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
_x000D_
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
_x000D_
• Provides insight into the market through Value Chain
_x000D_
• Market dynamics scenario, along with growth opportunities of the market in the years to come
_x000D_
• 6-month post-sales analyst support
_x000D_
Customization of the Report
_x000D_
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
_x000D_
Frequently Asked Questions
_x000D_
_x000D_
_x000D_
What is the projected market size & growth rate of the Neurostimulation Devices Market? _x000D_
_x000D_
_x000D_
_x000D_
Neurostimulation Devices Market was valued at USD 6.06 Billion in 2021 and is projected to reach USD 17.49 Billion by 2030, growing